Poolbeg Pharma PLC
Poolbeg Pharma identifies new RSV drug candidates

22.12.2022 / 11:47 CET/CEST
The issuer is solely responsible for the content of this announcement.

0.jpgContact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com


News Source: News Direct

22.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Poolbeg Pharma PLC
United States
ISIN: GB00BKPG7Z60
EQS News ID: 1520089

 
End of News EQS News Service

1520089  22.12.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1520089&application_name=news&site_id=webfg

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.